Grantham Mayo Van Otterloo & Co. LLC Sells 34,592 Shares of GE HealthCare Technologies Inc. $GEHC

Grantham Mayo Van Otterloo & Co. LLC reduced its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.1% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 308,033 shares of the company’s stock after selling 34,592 shares during the quarter. Grantham Mayo Van Otterloo & Co. LLC’s holdings in GE HealthCare Technologies were worth $23,133,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Wedge Capital Management L L P NC acquired a new stake in shares of GE HealthCare Technologies during the third quarter worth $26,859,000. Valicenti Advisory Services Inc. lifted its stake in GE HealthCare Technologies by 22.6% in the third quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock valued at $5,115,000 after buying an additional 12,550 shares during the period. Locust Wood Capital Advisers LLC lifted its stake in GE HealthCare Technologies by 7.1% in the third quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock valued at $156,534,000 after buying an additional 137,992 shares during the period. Nan Fung Trinity HK Ltd. bought a new position in GE HealthCare Technologies during the third quarter worth about $23,206,000. Finally, Envestnet Asset Management Inc. boosted its holdings in GE HealthCare Technologies by 15.8% during the third quarter. Envestnet Asset Management Inc. now owns 338,914 shares of the company’s stock worth $25,452,000 after buying an additional 46,231 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on GEHC shares. Piper Sandler upped their price target on GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a research note on Friday, January 30th. Morgan Stanley lifted their price objective on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 4th. Evercore boosted their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. Finally, Wall Street Zen upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a report on Saturday. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $92.50.

GE HealthCare Technologies Stock Down 3.7%

NASDAQ:GEHC opened at $74.27 on Monday. The stock has a 50-day simple moving average of $81.81 and a 200 day simple moving average of $78.61. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $89.77. The company has a market cap of $33.85 billion, a PE ratio of 16.29, a PEG ratio of 1.63 and a beta of 1.03. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. During the same quarter in the previous year, the business posted $1.45 EPS. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is currently 3.07%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.